Publicaciones (90) Publicaciones de MARÍA ÁNGELES VILLANÚA BERNUÉS

2019

  1. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats

    Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033

2017

  1. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway

    PLoS ONE, Vol. 11, Núm. 5

  2. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 310, Núm. 11, pp. E925-E937

  3. The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 7, Núm. 1, pp. 79-89

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. α MSH Blunts Endotoxin-Induced MuRF1 and Atrogin-1 Upregulation in Skeletal Muscle by Modulating NF- B and Akt/FoxO1 Pathway

    Mediators of Inflammation, Vol. 2014

2013

  1. Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 304, Núm. 10

2012

  1. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin

    Journal of Physiology and Pharmacology, Vol. 63, Núm. 6, pp. 649-659

  2. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats

    Growth Hormone and IGF Research, Vol. 22, Núm. 1, pp. 22-29

2011

  1. Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1

    Journal of Endocrinology, Vol. 210, Núm. 3, pp. 361-368

  2. Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 300, Núm. 5

2010

  1. Neurohipófisis

    Fisiología humana (McGraw Hill Education México), pp. 885-892

  2. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 299, Núm. 2

2009

  1. Cyclooxygenase-2 inhibition reverts the decrease in adiponectin levels and attenuates the loss of white adipose tissue during chronic inflammation

    European Journal of Pharmacology, Vol. 608, Núm. 1-3, pp. 97-103

  2. Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 297, Núm. 5

  3. IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting

    Molecular and Cellular Endocrinology, Vol. 309, Núm. 1-2, pp. 8-16

2008

  1. Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis

    Journal of Endocrinology, Vol. 197, Núm. 1, pp. 111-119

  2. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 1

  3. Ptgs2 activation by endotoxin mediates the decrease in Igf1, but not in Igfbp3, gene expression in the liver

    Journal of Endocrinology, Vol. 198, Núm. 2, pp. 385-394